Biotech to take spotlight at Oracle OpenWorld event

SAN FRANCISCO: Oracle's 13th annual OpenWorld event begins this

week with an increased focus on biotechnology and the company's own

intellectual capital.

For the first time, Oracle is focusing on the technology needs of the

biotech sector in a life sciences conference during OpenWorld. Mark

Jarvis, the company's SVP and chief marketing officer, said the sector

is one that has not been targeted in the past.

Oracle is also presenting a panel discussion featuring its top engineers

and architects in a session called, "Meet the Gurus," promising to

reveal some of the idiosyncrasies in product designs.

"After 24 years we have a lot of folklore that has never been public,"

Jarvis said. "These people are the genetic make-up of Oracle."

Larry Ellison, CEO of Oracle, will conduct a press conference about

OpenWorld on Tuesday, December 4. Registration stands at about 60,000

for the event, an increase of about 5,000 over last year.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in